2 completed, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow fispemifene: new trials by email Literature Review of fispemifene trials Research Report on fispemifene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men fispemifene, Placebo - Secondary Hypogonadism, Sexual Dysfunction | Phase 2 | Unknown | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | 160 | 2015-05-01 | 2015-11-13 |
| Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy Fispemifene - Hypogonadism, Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | QuatRx Pharmaceuticals Company | 15 | 2007-01-01 | 2010-02-03 |
| Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors Fispemifene (once daily for 8 weeks) - Hypogonadism, Erectile Dysfunction | Phase 2 | Completed | QuatRx Pharmaceuticals Company | 72 | 2006-12-01 | 2010-02-03 |
Hypogonadism (3) · Erectile Dysfunction (2) · Pulmonary Disease, Chronic Obstructive (1) · Sexual Dysfunction, Physiological (1)
QuatRx Pharmaceuticals Company (2) · NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) (1)
United States (2)
Barbara Troupin, MD, MBA (1) · Janne Komi, MD, PhD (1)